Form D · Biotechnology
MapLight Therapeutics, Inc.
Redwood City, CA · CIK 0001770069
Offering snapshot reported Jul 28, 2025 · SEC filing
- Reported sold
- $188M Offering amount: $372M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2025 | Initial | $188,187,915 | No comparison | 19 | SEC filing |
| Nov 3, 2023 | Amendment | $104,999,994 | $54,999,997vs Jul 19, 2023 | 12 | SEC filing |
| Jul 19, 2023 | Initial | $49,999,997 | No comparison | 5 | SEC filing |
| Nov 10, 2022 | Initial | $11,999,999 | No comparison | 1 | SEC filing |
| Mar 10, 2021 | Initial | $29,999,999 | No comparison | 2 | SEC filing |
| Sep 4, 2019 | Initial | $15,999,999 | No comparison | 2 | SEC filing |
| Mar 22, 2019 | Amendment | $5,000,000 | $0vs Mar 8, 2019 | 2 | SEC filing |
| Mar 8, 2019 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552922
Source: Form D, filed Jul 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Bisgaard | Director |
| Erin Foff | Executive |
| Timothy Garnett | Director |
| Jonathan Gillis | Executive |
| Kristopher Hanson | Executive |
| Anatol Kreitzer | Executive |
| Christopher A Kroeger | Director, Executive |
| James Lillie | Executive |
| Jim Lillie | Executive |
| Nanna Luneborg | Director |
| Charmaine Lykins | Executive |
| Robert Malenka | Director |
| George Pavlov | Director |
| Vishwas Setia | Executive |
| Jim Trenkle | Director |
| Maria Walker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
800 Chesapeake Drive
Redwood City, CA, 94063
Redwood City, CA, 94063